“Game-changing results” have been announced by a team of scientists using the immunotherapy drug nivolumab to treat certain lung cancers that failed to respond to first-line therapies.
“Game-changing results” have been announced by a team of scientists using the immunotherapy drug nivolumab to treat certain lung cancers that failed to respond to first-line therapies.